High Point Bank & Trust’s Edwards Lifesciences EW Stock Holding History

High Point Bank & Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$35K	Buy	+1,125	New	+$36.5K	0.01%	249

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

High Point Bank & Trust's EW Position: Q4 2016 in Review

High Point Bank & Trust opened a new position in Edwards Lifesciences (EW) in Q4 2016: 1,125 shares worth $35K. The stake represents 0.01% of the portfolio and ranks #249 among its holdings.

686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

High Point Bank & Trust held 1,125 shares of Edwards Lifesciences worth $35K as of Q4 2016.
Edwards Lifesciences was a new High Point Bank & Trust position in Q4 2016.
Edwards Lifesciences made up 0.01% of High Point Bank & Trust's portfolio in Q4 2016, its #249 holding.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.